Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

HIV diversity and genetic compartmentalization in blood and testes during suppressive antiretroviral therapy.

Miller RL, Ponte R, Jones BR, Kinloch NN, Omondi FH, Jenabian MA, Dupuy FP, Fromentin R, Brassard P, Mehraj V, Chomont N, Poon AFY, Joy JB, Brumme ZL, Routy JP; ORCHID study group.

J Virol. 2019 Jun 12. pii: JVI.00755-19. doi: 10.1128/JVI.00755-19. [Epub ahead of print]

PMID:
31189714
2.

Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection.

Mehraj V, Ramendra R, Isnard S, Dupuy FP, Ponte R, Chen J, Kema I, Jenabian MA, Costiniuk C, Lebouché B, Thomas R, Coté P, Leblanc R, Baril JG, Durand M, Chartrand-Lefebvre C, Tremblay C, Ancuta P, Bernard NF, Sheppard DC, Routy JP; Montreal Primary HIV-infection Study and Canadian HIV and Aging Cohort Study Groups.

Clin Infect Dis. 2019 Mar 16. pii: ciz212. doi: 10.1093/cid/ciz212. [Epub ahead of print]

PMID:
30877304
3.

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.

Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, Lebouché B, Cox J, Szabo J, Brouillette MJ, Klein MB, Chomont N, Jenabian MA.

BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.

4.

HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.

Costiniuk CT, Salahuddin S, Farnos O, Olivenstein R, Pagliuzza A, Orlova M, Schurr E, De Castro C, Bourbeau J, Routy JP, Ancuta P, Chomont N, Jenabian MA.

AIDS. 2018 Oct 23;32(16):2279-2289. doi: 10.1097/QAD.0000000000001962.

5.

Anti-Gag antibodies gag HIV infection and slow disease progression.

Ahmad A, Mehraj V, Jenabian MA, Routy JP, Tremblay C.

AIDS. 2018 Jun 19;32(10):1373-1375. doi: 10.1097/QAD.0000000000001852. No abstract available.

PMID:
29851665
6.

HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation.

Allam O, Samarani S, Mehraj V, Jenabian MA, Tremblay C, Routy JP, Amre D, Ahmad A.

PLoS One. 2018 Mar 30;13(3):e0194185. doi: 10.1371/journal.pone.0194185. eCollection 2018.

7.

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study.

Costiniuk CT, Mehraj V, Routy JP, de Castro C, Wasef N, Jenabian MA, Salahuddin S, Lebouché B, Cox J, Szabo J, Klein M, Lands L, Shapiro AJ.

AIDS Res Treat. 2018 Jan 9;2018:7645125. doi: 10.1155/2018/7645125. eCollection 2018.

8.

Characterization of myeloid cell populations in human testes collected after sex reassignment surgery.

Ponte R, Dupuy FP, Brimo F, Mehraj V, Brassard P, Belanger M, Yurchenko E, Jenabian MA, Bernard NF, Routy JP; ORCHID study group.

J Reprod Immunol. 2018 Feb;125:16-24. doi: 10.1016/j.jri.2017.10.043. Epub 2017 Oct 14.

PMID:
29136520
9.

Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.

Whyte-Allman SK, Hoque MT, Jenabian MA, Routy JP, Bendayan R.

J Pharmacol Exp Ther. 2017 Dec;363(3):324-335. doi: 10.1124/jpet.117.243584. Epub 2017 Sep 28.

PMID:
28970358
10.

Potential for False-Positive Results with Serological Assays for HIV in Central Africa: Implications for the HIV Serodiagnosis Algorithm According to the 2015 Consolidated WHO Recommendations for Resource-Constrained Countries.

Jenabian MA, Costiniuk CT, Talla P, Robin L, Tonen Wolyec S, Mboumba Bouassa RS, Bélec L.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1077-1079. doi: 10.1089/AID.2017.0059. Epub 2017 Aug 16. No abstract available.

PMID:
28670913
11.

Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.

Mboumba Bouassa RS, Prazuck T, Lethu T, Jenabian MA, Meye JF, Bélec L.

Expert Rev Anti Infect Ther. 2017 Jun;15(6):613-627. doi: 10.1080/14787210.2017.1322902. Epub 2017 May 5. Review.

PMID:
28440679
12.

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.

Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Mbitikon O, Jenabian MA, Robin L, Matta M, Zeitouni K, Longo JD, Costiniuk C, Grésenguet G, Touré Kane NC, Bélec L.

Medicine (Baltimore). 2017 Mar;96(10):e6282. doi: 10.1097/MD.0000000000006282.

13.

Analytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA Quantification.

Mossoro-Kpinde CD, Mboumba Bouassa RS, Jenabian MA, Wolyec ST, Robin L, Matta M, Longo JD, Grésenguet G, Andreoletti L, Bélec L.

AIDS Res Treat. 2016;2016:7954810. doi: 10.1155/2016/7954810. Epub 2016 Dec 5.

14.

Differential synthesis and release of IL-18 and IL-18 Binding Protein from human platelets and their implications for HIV infection.

Allam O, Samarani S, Jenabian MA, Routy JP, Tremblay C, Amre D, Ahmad A.

Cytokine. 2017 Feb;90:144-154. doi: 10.1016/j.cyto.2016.10.016. Epub 2016 Dec 1.

PMID:
27914933
15.

A potentially protective role of IL-18 Binding Protein in HIV-infected Long-Term Non-Progressors.

Iannello A, Samarani S, Allam O, Jenabian MA, Mehraj V, Amre D, Routy JP, Tremblay C, Ahmad A.

Cytokine. 2017 Feb;90:96-99. doi: 10.1016/j.cyto.2016.10.018. Epub 2016 Nov 16.

PMID:
27863336
16.

Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.

Jenabian MA, Costiniuk CT, Mehraj V, Ghazawi FM, Fromentin R, Brousseau J, Brassard P, Bélanger M, Ancuta P, Bendayan R, Chomont N, Routy JP; Orchid study group.

AIDS. 2016 Nov 28;30(18):2777-2786.

PMID:
27677162
17.

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.

Wacleche VS, Goulet JP, Gosselin A, Monteiro P, Soudeyns H, Fromentin R, Jenabian MA, Vartanian S, Deeks SG, Chomont N, Routy JP, Ancuta P.

Retrovirology. 2016 Aug 24;13(1):59. doi: 10.1186/s12977-016-0293-6.

18.

Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.

Ahmad A, Mehraj V, Jenabian MA, Samarani S, Tremblay C, Routy JP.

AIDS. 2016 Jul 17;30(11):1839-41. doi: 10.1097/QAD.0000000000001168. No abstract available.

PMID:
27351927
19.

Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Huang Y, Hoque MT, Jenabian MA, Vyboh K, Whyte SK, Sheehan NL, Brassard P, Bélanger M, Chomont N, Fletcher CV, Routy JP, Bendayan R.

J Antimicrob Chemother. 2016 Jul;71(7):1954-65. doi: 10.1093/jac/dkw046. Epub 2016 Apr 13.

20.

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.

Mehraj V, Jenabian MA, Ponte R, Lebouché B, Costiniuk C, Thomas R, Baril JG, LeBlanc R, Cox J, Tremblay C, Routy JP; Montreal Primary HIV Infection, the Canadian Long-Term Non-Progressors Study Groups.

AIDS. 2016 Jun 19;30(10):1617-27. doi: 10.1097/QAD.0000000000001105.

Supplemental Content

Loading ...
Support Center